Navigation Links
The MedZilla Report: March 2009 Employment Outlook for Biotech/Pharma/Health
Date:4/23/2009

Companies fighting to stay on budget as the first quarter of 2009 came to a close were forced to announce layoffs, and the U.S. economic crisis impacted a field once thought immune to the troubles of the rest of the country as job creation for March contracted by 50 percent.

Seattle, WA (PRWEB) March 23, 2009 -- As the first quarter of 2009 came to a close in March, several companies announced layoffs, and while many were small, companies serving the pharmaceutical, biotechnology, and health care industries all were affected. Even as 14,000 new health care jobs were created, the average job creation in the first quarter was only 17,000 per month, as opposed to 30,000 per month in 2008.

Generally, cuts in health care are being increased because more and more facilities are losing money. It is the smaller, specialty programs that are cut first -- such as youth residential centers -- but some companies, like Kaiser, have announced sweeping cuts of more than 800 jobs. Kaiser's situation is different in that they are eliminating their in-house information technology departments in favor of a new deal with IBM (Sacramento Business Journal, March 16, 2009). Other health systems, such as New York City's Health and Hospitals Corporation, were forced to lay off workers as Medicaid payouts decreased. The month's largest job cuts by far, however, came from biotechnology as Hospira announced a plan to eliminate almost 1,500 jobs over the next two years. Roche is also expected to lose 500 employees as they close their Palo Alto, Calif., research facility, and will likely see more decline the offer to move to other facilities in San Francisco and New Jersey.
   
Now that more companies are announcing layoffs as they see how far short they have fallen compared to their budgets, employees in danger of being laid off -- either real or perceived -- have increased their job searc
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related biology technology :

1. The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health
2. The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health
3. The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
4. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
5. Special Stockholders Meeting to Elect Directors Set for March 4, 2008
6. Harland Medical Systems to Offer March Plasma Systems Surface Materials
7. World Glaucoma Day Set for March 6th
8. Martek to Announce First Quarter 2008 Results on March 5, 2008
9. Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17
10. Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
11. WuXi PharmaTech Schedules Fourth Quarter and Full Year 2007 Earnings Release on Wednesday, March 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The MedZilla Report: March 2009 Employment Outlook for Biotech/Pharma/Health
(Date:3/25/2015)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... discussions with certain shareholders representing approximately 45% of the ... with certain matters including the appointment of auditors at ... 26, 2015 (the "Meeting") it intends to adjourn the ... place when the Meeting reconvenes. The Meeting will be ...
(Date:3/25/2015)... NEW YORK , March 25, 2015 /PRNewswire/ ... has commenced Factual Stock Report coverage on ... Bioceuticals (OTCQX: ATTBF; CSE: ATT): is a specialty ... subsidiaries of cultivating, licensing and marketing proprietary ingredients, ... medicinal markets in North America ...
(Date:3/25/2015)... and REYKJAVIK, Iceland , March 25, 2015 ... the genome to create better medicine, today congratulated the scientists ... of whole-genome data yet undertaken. The studies ... – are built around the most comprehensive population-wide tally ... deCODE scientists led by Kari Stefansson , deCODE,s founder ...
(Date:3/25/2015)... 25, 2015 Data from Evidence ... of Action in Neuromuscular Diseases , South ... Incorporated (Nasdaq: CYTK) announced the publication of a ... activator tirasemtiv in the journal Neurotherapeutics. This ... of Effect” or hypothesis-generating clinical trial which evaluated ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
... University bioengineers have not only figured out a way to ... can now slip them into the command center -- or ... important information or drop off payloads. Using silver nanoparticles ... an uncanny ability to penetrate human cells, the scientists ...
... Wis., Sept. 28 Sheffield Bio-Science, a Kerry ... and marketing alliance with Girus Life Sciences. Under ... Global Sales, Distribution and Development Partner for Girus ... Regocel supplements are small molecule yield enhancers ...
... Sept. 28 Decision Resources, one of the world,s ... issues finds that, owing to increasing generic availability of ... $26 billion in 2009 to $23 billion in 2019 ... Kingdom and Japan. The Pharmacor 2010 findings ...
Cached Biology Technology:Sneaking spies into a cell's nucleus 2Sneaking spies into a cell's nucleus 3Sheffield Bio-Science Adds Chemically Defined Media Supplements to Product Portfolio 2Due to Generic Erosion, the Hypertension Drug Market Will Decline by $3 Billion from 2009 to 2019 2
(Date:3/24/2015)...   NexID Biometrics LLC, whose spoof-mitigation technology ... announced the beginning of shipments of version 2.0 of ... company, based in Potsdam, N.Y. , ... which began here today at the Walter E. Washington ... its SDK boosts the accuracy rate range to 96.5 ...
(Date:3/23/2015)... 2015  In the 2014 fiscal year, irs.gov recorded ... This figure accounts for a fraction of the estimated ... Report, exceeds $11 billion globally. The polygraph has traditionally ... has occurred. Investor Mark Saint Juste along ... Paolella partnered to administer the test in a ...
(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... wallet is one of the products featured in 2015 ... 20th at 11:00 PM EST on the DIY Network. ... Las Vegas , site of the ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... technology that makes it possible to zoom in on ... at Dana-Farber Cancer Institute have identified nearly 100 chromosome ... non-small cell lung cancer. The findings provide new clues ... most common type of lung cancer –?and one of ...
... water quality, creation of coastal "dead zones," the collapse ... some of the potential consequences of humankind's degradation of ... report launched today. , Humans have changed ecosystems more ... in any other period, some 60 per cent of ...
... of molecular signals that instructs cells with fatally damaged DNA ... p53 is inactivated, as it is in over half of ... to operate, and body cells start to accumulate mutations, which ... this vital safeguard has been studied in great detail for ...
Cached Biology News:High-powered gene profiles provide clues to genes involved in common form of lung cancer 2High-powered gene profiles provide clues to genes involved in common form of lung cancer 3UN: World in big ecological mess 2UN: World in big ecological mess 3Cancer related gene p53 not regulated as indicated by previous tissue culture research 2Cancer related gene p53 not regulated as indicated by previous tissue culture research 3
Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f...
Mouse monoclonal antibody raised against a partial recombinant NEK2. NCBI Entrez Gene ID = NEK2...
... imaging controller is a successor of the ... users to comfortably observe, record and utilize ... an 8.4 inch LCD (XGA) monitor and ... cameras including the DS-Fi1 , DS-5Mc , ...
Biology Products: